The Great Stem Cell Divide
By Michelle L. Brandt,
Stanford Medicine Magazine
| 09. 30. 2004
The science and politics of stem cell research
Stanford physician Michael Lyons, MD, is not a stem cell researcher. But when the Connecticut House Speaker recently called him to discuss her "cautious, maybe even negative, feelings" about a state bill that would endorse embryonic stem cell research, the Stanford genetics fellow was happy to oblige. The state lawmaker felt uneasy about portions of the bill, so Lyons patiently defined complex scientific terms, clarified the differences between this type of research and reproductive cloning, and outlined what he saw as the merits of the work.
By the end of the conversation he had convinced his mom that she should support the legislation.
Lyons and his mother, Speaker Moira Lyons, are just two of many to dive into the debate surrounding stem cells, undeveloped cells that can be coaxed into growing into any kind of tissue. Stem cells are so small that they can't be seen with the naked eye, yet they tend to cause mass confusion and evoke the largest of responses. In fact, Moira Lyons blames the bill's eventual failure to pass in the Connecticut House on legislators'...
Related Articles
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...